Foropafant is primarily utilized in research settings as a potent and selective antagonist of platelet-activating factor (PAF) receptors. Its application is significant in studying the role of PAF in various physiological and pathological processes, such as inflammation, allergic reactions, and cardiovascular diseases. By blocking PAF receptors, Foropafant helps researchers understand the mechanisms underlying these conditions and explore potential therapeutic interventions. Additionally, it is used in experimental models to investigate the impact of PAF inhibition on immune responses and cellular signaling pathways.